Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Transcat (TRNS) EBITDA (2016 - 2025)

Transcat (TRNS) has disclosed EBITDA for 14 consecutive years, with $88000.0 as the latest value for Q4 2025.

  • Quarterly EBITDA fell 95.81% to $88000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $15.9 million through Dec 2025, up 41.28% year-over-year, with the annual reading at $17.9 million for FY2025, 361.62% up from the prior year.
  • EBITDA hit $88000.0 in Q4 2025 for Transcat, down from $3.5 million in the prior quarter.
  • In the past five years, EBITDA ranged from a high of $6.9 million in Q1 2025 to a low of -$6.9 million in Q1 2022.
  • Historically, EBITDA has averaged $2.8 million across 5 years, with a median of $3.6 million in 2021.
  • Biggest five-year swings in EBITDA: plummeted 251.99% in 2022 and later skyrocketed 2213.33% in 2025.
  • Year by year, EBITDA stood at $2.4 million in 2021, then surged by 33.97% to $3.2 million in 2022, then surged by 35.76% to $4.3 million in 2023, then plummeted by 51.09% to $2.1 million in 2024, then crashed by 95.81% to $88000.0 in 2025.
  • Business Quant data shows EBITDA for TRNS at $88000.0 in Q4 2025, $3.5 million in Q3 2025, and $5.3 million in Q2 2025.